BRIDGEBIO PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.01 USD | -2.91% |
|
+0.25% | -30.62% |
| May. 29 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
| May. 28 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.24B | - | |||||
| 89.87B | ||||||
| 37.57B | ||||||
| 26.47B | ||||||
| 14.25B | ||||||
| 12.99B |
